ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis.

April 30, 2004

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

Funding Opporunities: Program Announcments

January 15, 1999

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998